FGF-23 in children with CKD: a new player in the development of CKD–mineral and bone disorder
Nephrology Dialysis Transplantation, 08/03/2012
Clinical Article
Siomou E et al. – The bone–kidney–parathyroid endocrine axis mediated by fibroblast growth factor–23 should be a novel therapeutic target in clinical practice, even in early stages of chronic kidney disease in children.



